E-ISSN 2231-3206 | ISSN 2320-4672
 
2024, Vol: 14, Issue: 4
14 / 4Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Authorship Declaration

Original Research

Online Publishing Date:
06 / 03 / 2017

 


The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers

Ali Salih Baay.


Abstract
Background: For clinicians who work in respiratory medicine, the use of beta-blockers (BBs) has, for a long time, posed a dilemma because of the potential risk of bronchospasm and neutralization of the effectiveness of β-2 agonists.

Aims and Objectives: To observe the effect of nebivolol on clinical and spirometric parameters on patients with stable chronic obstructive pulmonary disease (COPD) and the effect of the reversibility magnitude on the nebivolol detrimental effects.

Materials and Methods: A total of 32 patients with age above 40 years regardless their smoking state from both genders were included in the study at College of Medicine, Babylon University from February 2014 to September 2016. The study was approved by Institutional Review Board. The study included the patients who were diagnosed as COPD. Patients were divided into two groups depending on the reversibility test in spirometric assessment.

Results: There were significant differences between means of forced expiratory flow (FEF), forced expiratory volume in 1 second (FEV1) and COPD assessment test (CAT) score before and after using of 3rd generation BB for all patients with COPD and patients with high reversibility percent while for patients with low reversibility percent were significant differences between means of FEF, while there were no significant differences between means of FEV1 and CAT score.

Conclusion: The reversibility percent can be used as an indicator for the adverse effect of BB on COPD patients.

Key words: Reversibility Test; Chronic Obstructive Pulmonary Disease; Nebivolol; Outcome Predictor


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Ali Salih Baay
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Ali Salih Baay. The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers. Natl J Physiol Pharm Pharmacol. 2017; 7(6): 628-633. doi:10.5455/njppp.2017.7.01235023012017

Web Style

Ali Salih Baay. The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers. https://www.njppp.com/?mno=253089 [Access: March 14, 2024]. doi:10.5455/njppp.2017.7.01235023012017

AMA (American Medical Association) Style

Ali Salih Baay. The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers. Natl J Physiol Pharm Pharmacol. 2017; 7(6): 628-633. doi:10.5455/njppp.2017.7.01235023012017


Vancouver/ICMJE Style

Ali Salih Baay. The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers. Natl J Physiol Pharm Pharmacol. (2017), [cited March 14, 2024]; 7(6): 628-633. doi:10.5455/njppp.2017.7.01235023012017


Harvard Style

Ali Salih Baay (2017) The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers. Natl J Physiol Pharm Pharmacol, 7 (6), 628-633. doi:10.5455/njppp.2017.7.01235023012017


Turabian Style

Ali Salih Baay. 2017. The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers. National Journal of Physiology, Pharmacy and Pharmacology, 7 (6), 628-633. doi:10.5455/njppp.2017.7.01235023012017


Chicago Style

Ali Salih Baay. "The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers." National Journal of Physiology, Pharmacy and Pharmacology 7 (2017), 628-633. doi:10.5455/njppp.2017.7.01235023012017


MLA (The Modern Language Association) Style

Ali Salih Baay. "The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers." National Journal of Physiology, Pharmacy and Pharmacology 7.6 (2017), 628-633. Print. doi:10.5455/njppp.2017.7.01235023012017


APA (American Psychological Association) Style

Ali Salih Baay (2017) The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers. National Journal of Physiology, Pharmacy and Pharmacology, 7 (6), 628-633. doi:10.5455/njppp.2017.7.01235023012017


Author LoginReviewer LoginAbout PublisherEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

  National Journal of Physiology, Pharmacy and Pharmacology is a monthly peer reviewed journal.  The journal is having open access polic ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Publisher

publishernjppp@gmail.com

 

Editorial query

editornjppp1@gmail.com

MOB - 8780040272